Name: TIZIANA LIFE SCIENCES LTD (TLSA) Stock
Brand: TIZIANA LIFE SCIENCES LTD
Rating: 4.5 (3 reviews)

TLSA Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Aquestive Therapeutics, Inc. - Mentions: AQST

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

8 days ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

a month ago - By: Stocktwits

Tiziana Life Sciences Stock Rises On Advancing Second Asset Besides Foralumab: Retail Thinks Stock Has ‘So Much Potential’

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

a month ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

2 months ago - By: Tiziana Life Sciences Ltd.

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury

2 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

2 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

2 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Purchase of Shares by Chairman

2 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Purchase of Shares by Chairman

3 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

3 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

3 months ago - By: Tiziana Life Sciences Ltd.

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

3 months ago - By: Tiziana Life Sciences Ltd.

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

3 months ago - By: Benzinga - Mentions: UBER LCID TSLA

Lucid Is Now Shipping Adapters That Let Customers Access Elon Musk-Led Tesla's Supercharger Network

4 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient

5 months ago - By: Benzinga - Mentions: ELVN HCTI SNES NCNA ...

12 Health Care Stocks Moving In Friday's Intraday Session

5 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

5 months ago - By: Tiziana Life Sciences Ltd.

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

5 months ago - By: Tiziana Life Sciences Ltd.